RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,110.00
+60.00 (0.85%)
At close: Dec 5, 2025
32.40%
Market Cap 61.62B
Revenue (ttm) 134.21B
Net Income (ttm) 4.89B
Shares Out 8.67M
EPS (ttm) 564.72
PE Ratio 12.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,031
Average Volume 72,329
Open 7,050.00
Previous Close 7,050.00
Day's Range 7,010.00 - 7,170.00
52-Week Range 4,635.00 - 9,130.00
Beta 0.62
RSI 44.12
Earnings Date n/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, and chewable soft capsules; non-synthetic and chewable tablets; hard capsules and jelly sticks; and granule, effervescent granule, and stick type capsule powders. The company was founded in 1983 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.